Issue Date: June 18, 2012
Lilly Invests In Chinese Generics
Eli Lilly & Co. is expanding its manufacturing network through a new investment in Novast Laboratories, a Chinese maker of generics and specialty drugs. Lilly invested in Novast several years ago through its Lilly Asian Ventures unit and will now invest an additional $20 million in the firm.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society